Karyopharm investigation initiated by former louisiana attorney general: kahn swick & foti, llc investigates the officers and directors of karyopharm therapeutics inc. - kpti

New orleans--(business wire)--former attorney general of louisiana, charles c. foti, jr., esq., a partner at the law firm of kahn swick & foti, llc (“ksf”), announces that ksf has commenced an investigation into karyopharm therapeutics inc. (nasdaqgs: kpti). on february 22, 2019, the federal drug administration ("fda") reported serious flaws in the new drug application and the underlying clinical trial data for the company's drug, selinexor. specifically, the fda detailed that the company's
KPTI Ratings Summary
KPTI Quant Ranking